Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Arjo announces date of 2017 year-end report and conference call

Arjo will issue its year-end report for 2017 on Monday January 29 at 08:00 CET, followed by a conference call at 09:00 CET, hosted by Joacim Lindoff, President & CEO, and Jonas Lindqvist, CFO.Arjo will issue its year-end report for 2017 on Monday January 29 at 08:00 CET, followed by a conference call at 09:00 CET, hosted by Joacim Lindoff, President & CEO, and Jonas Lindqvist, CFO. The publication date for Arjo’s report has been moved forward to an earlier date (the previously announced date was February 6) since Arjo was part of Getinge Group for a significant part of 2017, which will

Tytti Bergman appointed to Nokian Tyres management team as of April 16, 2018

Nokian Tyres plc Company Release January 5, 2018, 02:00 p.m. Ms. Tytti Bergman, M.Sc. (B.A.), age 48, has been appointed to the Nokian Tyres management team in the new position of SVP, People & Culture starting from April 16, 2018. Bergman will report to the President & CEO. Her main responsibilities will be the development of leadership and management team work, strategic talent management, strategy implementation and supporting change management in connection with development projects. Tytti Bergman is currently working as EVP, Personnel at Alko Inc, and has wide experience in

NRC Group ASA – Approved prospectus

Reference is made to the stock exchange announcement on 24 October 2017 by NRC Group ASA (the “Company”) regarding issuance of 512,895 new shares in the Company (the “New Shares”) in connection with the Company's acquisition of Fibertech AS. The Financial Supervisory Authority of Norway (Nw. Finanstilsynet) has today, 5 January 2018, approved a prospectus prepared by the Company for listing of the New Shares on the Oslo Stock Exchange. Following the publication of the prospectus, the New Shares will be transferred from a separate ISIN to the Company’s ordinary ISIN and be tradable on the

#18-21 Listing of Knock out warrants issued by BNP Paribas Issuance B.V.

As from January 08, 2018, 3 Knock out warrants issued by BNP Paribas Issuance B.V. will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: BNP Paribas Issuance B.V. Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from January 08, 2018 and forward or until time for knock out event Market Maker: BNP Paribas Arbitrage SNC Underlying: DAX 30 Index Current values of strike and barrier can be found at: [ NGM Market Data Web -

#18-20 Listing of Turbo warrants issued by BNP Paribas Issuance B.V.

As from January 08, 2018, 3 Turbo warrants issued by BNP Paribas Issuance B.V. will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: BNP Paribas Issuance B.V. Type of security: Call Turbo warrants of European type Execution: Automatic cash settlement Term: As from January 08, 2018 to expiry date Market Maker: BNP Paribas Arbitrage SNC Underlying: DAX 30 Index OMXS30 index For more details see attached file. For further information concerning this NGM notice please contact:

#18-19 Listing of Mini futures issued by BNP Paribas Issuance B.V.

As from January 08, 2018, 2 Mini futures issued by BNP Paribas Issuance B.V. will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: BNP Paribas Issuance B.V. Type of security: Mini futures, open ended Execution: Automatic cash settlement Term: As from January 08, 2018 and forward or until time for knock out event Market Maker: BNP Paribas Arbitrage SNC Underlying: DAX 30 Index OMXS30 index Current values of strike and barrier can be found at: [ NGM Market Data Web -

#18-18 Delisting of Instruments because of early termination issued BNP Paribas Issuance B.V.

After the end of today’s trading, 1 instrument issued by BNP Paribas Issuance B.V. will be delisted from Structured Products FI.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 10 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete

#18-17 Listing of Turbo warrants issued by Commerzbank AG

As from January 08, 2018, 6 Turbo warrants issued by Commerzbank AG will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: Commerzbank AG Type of security: Call Turbo warrants of European type Execution: Automatic cash settlement Term: As from January 08, 2018 to expiry date Market Maker: Commerzbank AG Underlying: DAX 30 Index OMXS30 index For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or

#18-16 Listing of Knock out warrants issued by Commerzbank AG

As from January 08, 2018, 3 Knock out warrants issued by Commerzbank AG will be listed on ETP Finland and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Finland Oy.Issuer: Commerzbank AG Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from January 08, 2018 and forward or until time for knock out event Market Maker: Commerzbank AG Underlying: DAX 30 Index Current values of strike and barrier can be found at: [ NGM Market Data Web - KnockOutWarrants ] 

Veidekke to build wind farms for Eolus Vind

Eolus Vind AB has awarded Veidekke the contract to build two wind farms outside Sundsvall in Sweden. This is a design and build contract valued at SEK 325 million. The work includes new construction of roads, crane plans, a complete electricity grid and 61 concrete foundations for the wind turbines. Work on the project will start immediately and is scheduled for completion in the spring of 2019. "Veidekke and Eolus have built a number of wind farms together with great success. With Veidekke's involving work methods we exploit all of our expertise and create the best solutions for the

Episurf Medical will exhibit at the Freiburger Knorpeltage, held in Freiburg im Breisgau, Germany, on January 19-20

Episurf Medical (NASDAQ: EPIS B) will exhibit at the Freiburger Knorpeltage (Freiburg Cartilage Days), an orthopaedic conference held in Freiburg im Breisgau, Germany (Freiburg Concert Hall), on January 19-20. For full program, see http://www.freiburger-knorpeltage.de. For an overview of the industry conferences attended by Episurf Medical, see link. (www.episurf.com/healthcare-professionals/conferences).  For more  information, please contact: Pål Ryfors, CEO, Episurf Medical Tel:+46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical

Oncology Venture Sweden AB announces approval on passportation of prospectus

Oncology Venture Sweden AB ("Oncology Venture") hereby announces approval on passportation of the prospectus. The Swedish Financial Supervisory Authority has issued an approval on passportation of Oncology Venture’s prospectus offering for subscription of shares in Denmark. The English version of the prospectus is available via the company´s (www.oncologyventure.com), AktieTorget´s (www.aktietorget.se) and Sedermera Fondkommission´s (www.sedermera.se) respective websites.Financial advisor Sedermera Fondkommission is the financial advisor to Oncology Venture in connection with the rights

Closing completed in connection with acquisition of Horisen Messaging in Switzerland

Reference is made to the stock exchange announcement from LINK Mobility Group ASA ("LINK" or the "Company") on 13th of December 2017 regarding the signing of a definitive agreement for the acquisition of Swiss mobile messaging business ("Horisen Messaging") from the Swiss mobile messaging company Horisen AG. LINK has today completed the acquisition of Horisen Messaging AG by acquisition of all shares. The acquisition was completed based on an agreed enterprise value of EUR 9 million, on a cash-free and debt-free basis. The enterprise value is based on a normalized EBITDA of EUR 1.8

Meet Senzime at WSM in London, 10-12 January

NEWS; Uppsala, January 5, 2018. For over 30 years the Winter Scientific Meeting (WSM) in London has been a great way for anaesthetists to develop their specialty knowledge and network with the wider anaesthesia community over three days. http://www.wsmlondon.org/ Senzime will be exhibiting the TetraGraph in booth number 48, together with the distributor for UK and Ireland, Wardray Premise. A workshop lead by Dr. Grant Rodney, Neuro-muscular junction (NMJ) monitoring, will be held during the meeting to highlight the value of neuromuscular monitoring in clinical

Electronics specialist Iftest improves efficiencies using IFS Applications

Iftest replaces exisiting ERP solution with an IFS solution to support its facilities in Switzerland and Slovakia IFS , the global enterprise applications company, announces that Iftest AG, a leading developer and manufacturer of medical and industrial electronics, has decided to implement IFS Applications™9.IFS Applications will support Iftest's central business processes with a continuous flow of information, increase transparency and improve the responsiveness of employees. The IFS solution will be utilized throughout the company and encompass the areas

SRV to launch construction work on new Siltasairaala Hospital for HUS

SRV GROUP PLC                               INVESTOR NEWS                                      5 JANUARY 2018, AT 11.00SRV to launch construction work on new Siltasairaala Hospital for HUS The Hospital District of Helsinki and Uusimaa HUS has made the decision to launch the implementation phase of the Siltasairaala Hospital in collaboration with SRV. The construction site of the Siltasairaala Hospital, the largest construction project in the history of HUS, will start up in early 2018. In connection with the Siltasairaala Hospital, a separate investment project comprising radiotherapy

Sea Shepherd Celebrates New Year with Arrest of Illegal Fishing Vessel in Liberia

FOR IMMEDIATE RELEASE January 5, 2018 On January 2nd, the Chinese-flagged fishing vessel (F/V) Guo Ji 809 was arrested by the Liberian Coast Guard -- with the assistance of the marine conservation organization Sea Shepherd -- for illegal fishing in waters belonging to the West African state of Liberia. Sea Shepherd’s vessel M/Y Sam Simon detected the fishing vessel by radar as it navigated Liberian waters at a speed indicating trawling activity. A Liberian Coast Guard Boarding Team quickly mobilized on board the M/Y Sam Simon and proceeded to the target where it was discovered that

HIDDN SIGNS AGREEMENT TO START DELIVERY OF 500 UNITS OF ITS LAPTOP 1+ AND KEY MANAGEMENT SYSTEM

Hiddn has received an order for 500 Laptop 1+ (encrypted internal hard drive for use in laptops) and a Key Management System for professional and governmental use from a new client in the Middle-East region. This first order was received after a period of extensive testing and final approval by the client.  Hiddn will process and deliver the order subsequently, after receiving settlement of the full value of the first 500 discs agreed to EUR 375,000.-.  Hiddn’s encryption product suite offers a distinctly superior level of safety and ensures that sensitive information stays

Cantargia receives patent approval in China for antibody treatment against IL1RAP in solid tumours

Cantargia AB (“Cantargia”) announces that the Chinese patent office, the State Intellectual Property Office (“SIPO”), has formally approved the company’s patent application for IL1RAP as target molecule for antibody therapy of several types of solid tumours. The granted patent has number ZL201280014136.7.Cantargia is developing antibodies against IL1RAP for treatment of life-threatening diseases. The company’s main project, the immuno-oncology antibody CAN04, is undergoing a clinical phase I/IIa trial focusing on treatment of non-small cell lung cancer and pancreatic cancer. The patent

Update on Opus’ Notice of Contract Award from New Jersey

The State of New Jersey, Department of Treasury, issued a Letter upholding a protest filed by a competitor and rescinding the Notice of Contract Award to Opus Inspection, Inc. (Opus) issued on August 23, 2017.Opus is in the process of reviewing its legal options.   Opus is currently not the incumbent contractor for the vehicle inspection program in the State of New Jersey. Gothenburg, January 5, 2018Opus Group AB (publ) This information is information that Opus Group AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for

Prospectus regarding ChromoGenics’ rights issue published

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, NEW ZEALAND, SOUTH AFRICA, CANADA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.The prospectus regarding the rights issue in ChromoGenics AB (publ) has been approved and registered with the Swedish Financial Supervisory Authority and is available (in Swedish only) on the ChromoGenics website, www.chromogenics.com/sv/investerare , and on Evli

Bonava carries out investor transaction and sells 75 apartments in Finland

On 20 December 2017, Bonava carried out an investor transaction in Vantaa, Finland. The purchaser was the investor ICECAPITAL Housing Fund IV Ky and the transaction encompassed 75 rental apartments.- This transaction is aligned with our strategy to develop additional rental projects and investor sales in Finland and our other markets, says Joachim Hallengren, President and CEO of Bonava. The area in which the rental project is located has good transport links to Vantaa city centre and Helsinki Airport. The apartments are situated near schools, cinemas, stores and green areas. The

Lundbeck enters research partnership on novel treatment of schizophrenia

H. Lundbeck A/S (Lundbeck) now adds another novel approach to its efforts to research and develop new and better treatments for schizophrenia. Forming a partnership with Vanderbilt University (Vanderbilt), Lundbeck both acquires an exclusive license and enters a research collaboration regarding Vanderbilt’s research program aimed at a novel approach to treating schizophrenia.Lundbeck and Vanderbilt will collaborate on further developing compounds invented by Vanderbilt with a new way of working in the brain compared to existing treatments. Tests in mice have indicated the new approach to

Skanska invests EUR 50M, about SEK 480M, in the second phase of an office project in Warsaw, Poland

Skanska invests EUR 50M, about SEK 480M in the second phase of Generation Park, an office project located in Warsaw, Poland. The second building, with a total leasable area of about 18,300 square meters, will comprise 16 stories above ground and two stories of underground parking. The investment will also include four underground parking levels for the planned third building.Generation Park will be Skanska’s largest office development in Central and Eastern Europe. The complex will comprise of three office buildings with a total leasable area of around 84,000 square meters. The project is

There are no items matching the current filter
There are no more items matching the current filter
Back to top